Who is supporting healthcare innovation for the 50+ market? You decide.

Individuals who serve in roles supporting healthcare innovation often defy easy categorization. Some serve as mentors, working within health systems to collaborate with entrepreneurs and steer them toward achievable goals.

Others have worked as investors, vetting hundreds of healthcare startups to find ones with the right balance of management team, solid business models and improving outcomes.

Still others lead startups that target the 50+ market but don’t easily match conventional healthcare categories.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab

Back in October of last year, MedCity announced it was partnering with AARP to unearth the people, ideas and companies innovating for the vital and growing 50+ market.

Since we started the nomination process, more than 150 entries were collected through November 2016. Now through stages, we want to arrive at the final 50 Innovation 50+ Leaders.

This week, we invite readers to pick their favorite individual nominees driving innovation among healthcare entrepreneurs and investment.